1 We describe the effects of pretreatment with 5-hydroxytryptamine (5-HT) receptor agonists and antagonists on neurogenically-mediated plasma protein extravasation (["25I]-albumin) in rat dura mater and in extracranial tissues (temporalis muscle fascia, conjunctiva, eyelid and lip) induced by electrical stimulation of the right trigeminal ganglion. 2 Leakage of [25I]-bovine serum albumin from blood vessels in dura mater following high intensity stimulation (1.2 mA, Sims, 5Hz for 5min) was significantly reduced by the intravenous administration of drugs active at 5-HT receptors with some selectivity for the 5-HT1 receptor subtypes: 5-carboxamidotryptamine (5-CT) (threshold dose, 1ngkg-1); 5-benzyloxytryptamine (5-BT) (10, 30 or 100augkg-1); 8-hydroxydipropylaminotetralin (8-OH-DPAT) (300pigkg-1); and as previously reported, sumatriptan (lOOpugkg -), dihydroergotamine (DHE) (SOugkg 1), ergotamine tartrate (lOO1ugkg 1) and chronically administered methysergide (1 mgkg-1).
Introduction
calcitonin gene-related peptide) from perivascular sensory fibres (Saria et al., 1985) . In the dura mater there is ultrastrucNeurogenic inflammation (vasodilatation and plasma protein tural evidence for mast cell degranulation, platelet accumulaextravasation) may be important to the pathophysiology of tion, and increase in the number of endothelial vesicles migraine headaches and to the action of antimigraine drugs specifically in postcapillary venules following electrical stimu- (Chapman et al., 1961; Dalessio, 1974; Moskowitz et al., 1979; lation Dimitriadou et al., 1990) . Protein Fozard, 1982; Hardebo, 1984;  Moskowitz, 1984; al., leakage does not develop in the dura mater after pretreatment 1988). Neurogenic plasma extravasation develops in dura with clinically relevant doses of the antimigraine drugs mater and extracranial cephalic tissues following electrical trisumatriptan, and the ergot alkaloids ergotamine tartrate, geminal stimulation or systemic capsaicin administration and dihydroergotamine and chronic methysergide (Saito et al., can be detected by leakage of albumin tracer (Markowitz et 1988; . Furthermore, the ultrastrucal., 1987 ). Extravasation appears to be mediated in part by tural changes are blocked by sumatriptan and dihydroergotreleased neuropeptides (e.g., substance P, neurokinin A, and amine . The pharmacological data suggest that a 5-HT receptor 1 Author for correspondence.
subtype mediates this response. To define more clearly the ,'-. Macmillan Press Ltd, 1991 5-HT receptor which mediates the blockade of neurogenic plasma extravasation, we examined extravasation in the dura mater in the presence of drugs active at a variety of 5-HT subtypes. The possibility that the 5-HT receptor mediating this response resides on sympathetic fibres innervating blood vessels of the dura mater was also examined. . After the stimulation period, the animals were promptly perfused with saline via the left cardiac ventricle for 2 min at a constant pressure of 100 mmHg (approximately 100 ml) in order to remove completely iodinated albumin from blood vessels. The anaesthetized animals died during this procedure. The skull was then opened, the brain removed and the cranial cavity thoroughly rinsed with saline. Dura mater was dissected bilaterally as previously described (Markowitz et al., 1987) . The large dural sinuses, the region of dura through which the electrodes penetrated, and the dura covering the trigeminal ganglion were excluded from analysis. Fascia covering the temporalis muscle (approximately 3.5mg wet weight), conjunctiva, eyelid and lip were dissected on both sides and levels of radioactivity determined (Micromedic Systems Inc., Huntsville, AL, U.S.A. The ratio between stimulated and non-stimulated sides ranged from 1.4 + 0.1 to 2.2 + 0.2 in dura mater (70 experiments, n = 400). Larger ratios with greater variances were observed in extracranial tissues at this current intensity and ranged from 2.3 + 0.3 to 4.8 + 1.0 in conjunctiva (13 experiments, n = 52), and from 1.3 + 0.1 to 2.8 + 0.3 in fascia (9 experiments, n = 36) ( Table 2 ).
Low intensity stimulation (0.1 mA, Sims, 5Hz, 3min) A significant increase in iodinated albumin was observed in extracranial tissues (conjunctiva, eyelid and lip) but not dura mater.
The ratio between the two sides in 4 separate experiments ranged from 1.5 + 0.1 to 1.9 + 0.4 in conjunctiva, 1.2 + 0.1 to 1.8 + 0.2 in the eyelid, and 1.5 + 0.2 to 2.0 + 0.2 in lip in vehicle-treated animals. Because these ratios most closely approximated the response in dura mater at higher currents, 0.1 mA for 3 min was used in subsequent experiments to determine whether sumatriptan could block extravasation in extracranial tissues.
S-HT receptors and the neurogenic inflammatory response in dura mater
Plasma protein leakage in dura mater did not differ on the unstimulated side between vehicle-and drug-treated animals.
The data (c.p.m. mg-1 wet wt.) contralateral to stimulation following 5-CT administration (1, l00ngkg-1) was 7.1 + 0.4 (n = 32) versus 8.3 + 0.6 (control, n = 32); 12.1 + 1.1 (5-BT, 10-300jigkg', n = 29) versus 12.8 + 0.9 (n = 25, control);
11.1 + 1.2 (8-OH-DPAT 100,300pugkg', n = 20) versus 10.9 + 1.2 (n = 15, control); 10.3 + 1.0 (sumatriptan 30-300pg kg-1, n = 28) versus 10.2 + 0.9 (n = 21; control). Data on the unstimulated side from conjunctiva and fascia also showed no differences between vehicle-and drug-treated animals (data not shown). 100%, respectively; 300pgkg-1 did not reach statistical significance (Figure 2) . 5-BT did not exhibit any effect in conjunctiva (Table 2) .
Sumatriptan High intensity stimulation: Pretreatment with sumatriptan (100pgkg-') decreased the ratio in dura mater [1.8 + 0.1 (n = 24) in vehicle-treated animals vs 1.1 + 0.0 (n = 23) in sumatriptan-treated group, P < 0.001].
Low intensity stimulation: The administration of either 100 or 300#ugkg-1 did not block the response to electrical stimulation in extracranial tissues. (Table 2 ).
Putative 5-HT1 receptor antagonists Pretreatment with metergoline or methiothepin at high concentrations (1 mg kg-1) significantly decreased the ratio in dura mater [1.9 + 0.1 (n = 9; control) vs 1.2 + 0.1 (n = 9) (P < 0.001) and 1.8 + 0.1 (n = 7; control) vs 1.2 + 0.1 (n = 7) (P < 0.001), respectively]. Metergoline (100, 500pgkg-1) or methiothepin (300,ug kg-') were without effect. (Table 2) .
Pretreatment with 5-HT antagonists prior to sumatriptan or 5-CT administration The effect of sumatriptan in dura mater was partially antagonized by metergoline, 100,ugkg-1: vehicle-treated 1.8 + 0.1 (n = 10); sumatriptan-treated 1.1 + 0.1 (n = 9, P < 0.001 as compared to the vehicle group); Vehicle (n) 1.6 + 0.1 (9) 1.9 ± 0.2 (6) 1.7 + 0.1 (4) 1.9 ± 0.2 (10) metergoline + sumatriptan 1.6 ± 0.1 (n = 10, P < 0.05 as compared to the sumatriptan group) (Figure 3 ). Methiothepin 300#gkg-t given 16min before sumatriptan 100.ugkg-1, did not antagonize the sumatriptan-induced blockade (Figure 3b ). The administration of 5-BT 30,ugkg-1 prior to sumatriptan added to the effect of sumatriptan: 2.2 + 0.2 (n = 3; control), 1.4 + 0.2 (n = 3; sumatriptantreated group; P < 0.05 as compared to control), 1.0 ± 0.1I in sumatriptan + 5-BT-treated group (n = 3, P < 0.05 as compared to the vehicle group). Neither pizotifen (300,ug kg-1) nor MDL 72222 (300 ,ug kg-) inhibited the effect of sumatriptan (Figure 3c,d) 1.9 + 0.1 (vehicle, n = 16) to 1.3 + 0.1 (n = 8) or 1.2 + 0.2 (n = 4), respectively, whereas after metergoline pretreatment at 100jg kgt the ratios were 1.2 + 0.1 (n = 8) and 1.4 + 0.1 (n = 4), respectively. When larger doses of metergoline (300pgkg-1) were administered prior to 5-CT at 1 or 300ngkg'-, the ratios between the two sides (1.0 + 0.1, n = 4 and 1.3 + 0.1, n = 7, respectively) did not differ from the response to 5-CT alone (1.3 + 0.1, n = 4, and 1.2 + 0.1, n = 7, respectively).
Sympathectomy and sumatriptan In rats previously subjected to unilateral superior cervical ganglionectomy, radioactivity (c.p.m. mg'-wet wt.) on the unstimulated sides was similar to those in normal animals. However, a slight increase in the ratio 
5-HTB/S-HTlD receptor binding sites
In the mid 1980's, two distinct but analogous subtypes of 5-HT1 receptor were identified in various species (Heuring et al., 1986) . 5-HTlB receptors are pharmacologically distinct from 5-HT1D receptors, yet appear to mediate similar functions in different species. 5-HT1B sites display <lOnM affinity for 5-CT and moderate affinity for 5-BT, sumatriptan, methiothepin and metergoline (Table 3 ). The 5-HT1B receptors are species specific (Hoyer & Middlemiss, 1989) . 5-HT1B binding sites have been demonstrated in rat and mouse brain and in a cell line derived from opossum kidney cells (Murphy & Bylund, 1988) , but not in guinea-pig, cow, chicken, turtle, frog, or human tissues (Hoyer et al., 1986; Heuring et al., 1986) . 5-HTlB receptors also appear to exist outside the central nervous system in rats and mice (see Middlemiss & Hudson, 1990 ).
In 1987, another distinct subtype of the 5-HT1 receptor 'family' was identified in bovine-brain membranes (Heuring & Peroutka, 1987) .
[3H]-5-HT binding in bovine caudate was examined in the presence of 100nm 8-OH-DPAT and 100nm mesulergine, a condition designed to displace over 90% of specific binding to 5-HTlA and 5-HT1c receptor sites (Heuring & Peroutka, 1987) . However, a significant amount of [3H]-5-HT binding was still observed under such conditions. Moreover, the pharmacological characteristics of this site did not correlate with any known 5-HT receptor subtype. Therefore, this recognition site for [3H]-5-HT was designated the '5-HT1D' binding site (Heuring & Peroutka, 1987) . It has been suggested that the 5-HT1D receptor is the receptor site responsible for the actions of ergot alkaloids and sumatriptan in migraine headaches .
Among the 5-HT1 receptor subtypes identified to date, the 5-HT1l/5-HTlD subtypes appear most relevant to neurogenic plasma extravasation in dura mater. Based on the threshold concentrations, the potency order among the tested drugs was 5-CT > 5-BT/dihydroergotamine (Saito et al., 1988 )/ sumatriptan > 8-OH-DPAT, reflecting the potency order of the affinities for the 5-HT1B/5-HTlD receptors of these drugs (Table 3) .
(ID50 values were difficult to calculate in this model because of the narrow range between threshold and maximum response.) The 5-HTlB/5-HTlD subtypes take on significance because the effect of sumatriptan can be blocked partially by metergoline (an antagonist with high affinity for the 5-HT1_/5-HT._ recognition site) and because sumatriptan and 5-BT bind with higher affinity to 5-HTID than 5-HTlA receptors (Peroutka et al., 1990) The plasma protein extravasation data shown are derived from the current study. Radioligand binding affinities were derived from Hoyer et al., 1985; Heuring & Peroutka, 1987; Offord et al., 1988; Schlicker et al., 1989; Waeber et al., 1988; Peroutka et al., 1990 and Peroutka (unpublished observations and because both sumatriptan and 5-BT exhibit only weak activity at 5-HT2 and 5-HT3 receptors. Similarly, 5-HTlB/5-HTlD receptors probably mediate the blockade of extravasation by less specific drugs such as methysergide.
On the other hand, our data suggest that an additional, as yet unidentified subtype(s) of the 5-HT1 receptor might be more involved in the inhibition of plasma leakage. Important differences from the predicted effects of these drugs at a known 5-HT1 receptor subtype(s) include: (1) the high potency (1 ng kg-1, threshold) of the non-selective agonist 5-CT, (2) the inability of metergoline to block the effects of 5-CT (metergoline, 100 or 300pugkg-1, given 10min prior to 5-CT, 1 or 300 ng kg-1, did not inhibit the effects of 5-CT in dura mater), (3) the partial inhibition of the action of sumatriptan by metergoline, (4) the inability of methiothepin pretreatment to affect inhibition by sumatriptan of plasma leakage, (5) the ability of the antagonists to promote plasma extravasation when administered alone, and (6) the lack of effect of 5-HT (see below) in this model. The development of more selective drugs to discriminate and identify other 5-HT1 receptor subtypes might help to resolve some of these questions, especially since much of the discrepant data involves the use of 5-HT1 antagonists.
Receptor localization
Several lines of experimental evidence support the conclusion that 5-HT heteroreceptors are located on neuropeptidecontaining unmyelinated C fibre and that drug blockade of plasma leakage within dura mater is mediated by a prejunctional mechanism. Firstly, sumatriptan (100 or 300pugkg-1, i.v.) and dihydroergotamine (50,pg kg-1, i.v. or (Saito et al., 1988; . Secondly, dihydroergotamine (SOpgkg-1) and to a lesser extent sumatriptan (300pg kg-') attenuate the increases in immunoreactive calcitonin generelated peptide within sagittal sinus blood (e.g., venous effluent) during electrical stimulation of the trigeminal ganglion (Buzzi et al., 1991) . Thirdly, sumatriptan and dihydroergotamine pretreatment block platelet aggregation and endothelial vesicle formation within post-capillary venules and mast cell secretion and degranulation in the dura mater (Perney et al., 1986 ).
The natural ligand for the putative 5-HTlB/5-HTlD receptor identified on trigeminal perivascular fibres is most probably 5-HT. However, 5-HT itself is relatively inactive in the model studied here. In fact, pretreatment with 5-HT does not cause plasma extravasation after intravenous administration, except at very large concentrations (1lumol kg-') (Markowitz et al., 1987), nor does it block the extravasation response following electrical stimulation or capsaicin administration. In one experiment (n = 3 per group), the response to capsaicin (149% + 0.5 versus 100% + 0.5 vehicle) was unaffected by 5-HT pretreatment (0.1 ,pmol kg-1; 150% + 12).
The possibility that blockade of neurogenically-mediated extravasation is due to decreases in surface area and perfusion pressure secondary to vasoconstriction (e.g., postjunctional mechanism) deserves consideration. Sumatriptan constricts isolated canine saphenous vein (Humphrey et al., 1988) , canine and primate cerebral vessels (Connor et al., 1989) , canine carotid arterial circulation . Ergotamine constricts isolated extracranial arteries (Muller-Schweinitzer & Weidmann, 1978) . In vivo, methysergide selectively constricts the carotid vascular bed (Saxena, 1974) . Sumatriptan , ergotamine (Bom et al., 1989a) , 5-CT (Saxena & Verdouw, 1985) and 8-OH-DPAT (Bom et al., 1989b) constrict arteriovenous shunts, although the effects of ergotamine may not be mediated by 5-HT1-like or 5-HT2 receptors (Bom et al., 1989a) . If closing arteriovenous shunts decreases vascular permeability following trigeminal stimulation, than leakage induced by intravenously administered neuropeptides (substance P or neurokinin A) should have been blocked as well. Constriction of arterioles (such as with phenylephrine) does not block neurogenic plasma extravasation nor does it reduce the increase in levels of calcitonin gene-related peptide in the sagittal sinus accompanying electrical stimulation (Saito et al., 1988; . Constriction of extracranial cephalic blood vessels follows ergotamine administration but neurogenic plasma extravasation is not blocked in these tissues. Finally, it would be difficult to conceive how a vasoconstrictor drug action alone would explain the blockade of neuropeptide increases in sagittal sinus, platelet accumulation and mast cell degranulation accompanying trigeminal stimulation has been documented in man (Sweet & Wepsic, 1974; Drummond et al., 1983; Goadsby et al., 1988) and experimental animals (Jancso-Gabor & Szolcsanyi, 1972; Couture & Cuello, 1984; Goadsby et al., 1988) . Both neurogenic plasma extravasation and headache can be blocked by aspirin and in selected cases, by indomethacin pretreatment (Buzzi et al., 1989) . A central role in migraine pathogenesis has been proposed for dural vessels (Penfield & McNaughton, 1940) . Dural vessels are among the few pain-sensitive intracranial tissues (Ray & Wolff, 1940) ; they contain structures important to the development of neurogenic inflammation, namely fenestrated capillary venules surrounded by a network of neuropeptide-containing unmyelinated C-fibres and mast cells (McNaughton, 1938; Andres et al., 1987) . Platelet aggregation, mast cell degranulation, and fluid accumulation in the perivascular space of postcapillary venules attendant on electrical trigeminal stimulation may promote sensitization of polymodal nociceptors and sustain the process of sterile inflammation (Cline et al., 1989) . It is possible that the consequences of neurogenic inflammation such as local fluid accumulation, sensitization of polymodal nociceptors and release of proinflammatory agents underlie and sustain the pain of headache. The ability of putative S-HT1 receptor agonists which lack inherent analgesic properties, to prevent neurogenic plasma extravasation in the dura mater, not only suggests an action directly on primary afferent fibres, but in itself adds further weight to the notion that dural inflammation may be relevant to headache pathogenesis. Peripheral (dural) mechanisms are further emphasized by the observation that sumatriptan is hydrophilic and penetrates the blood brain barrier very poorly, if at all (P.P.A. Humphrey, personal communication). For the above reasons vasoconstriction must diminish in importance as a mechanism to explain the analgesic action of these drugs in headache patients. Rather, the data favour the importance of neurogenic inflammation in the pathogenesis of migraine, and the unmyelinated C-fibre as the site of the putative 5-HT receptor subtype.
